Joseph Cummins, Kent Heckenlively

Case for Interferon (eBook, ePUB)

How a 1980s Cancer Drug Might Be the Wonder Therapy for the Twenty-First Century

• Format: ePub

Produktbeschreibung

Touted as a potential breakthrough cancer therapy in the 1980s by the scientific community and publications such as TIME and Newsweek magazine, the reputation of interferon has not lived up to its early promise. Interferons are small proteins with anti-viral and anti-cancer effects, which have the power to modulate the functioning of the immune system. But Dr. Joseph Cummins, an early interferon pioneer, holder of sixteen US medical patents, author of more than sixty scientific publications, as well as having taught veterinary medicine at the University of Missouri, University of Illinois, and Texas A & M University, argues that the current thinking on interferon is fundamentally flawed. Interferon is created in small quantities in the body in response to infection, and seems to work best at these low dosages. However, the public health cowboys, working under the assumption that anything good in tiny amounts must be better in massive amounts, pursued exactly the wrong strategy. High-dose interferon does not work in the body and may even cause problems. The first remarkable results for interferon and the flu were reported by the Soviets in the 1970s, but Western medicine discounted these findings because they believed the dosages were so low they couldn't possibly be effective. In the 1980s, when interferon was expensive to produce and only small quantities could be manufactured, the results were remarkable. Dr. Cummins was an early pioneer of low-dose interferon, and his remarkable findings among animals led to collaborations with medical doctors for human trials, even going so far as Africa at the height of the HIV-AIDS epidemic. Cummins reviews the evidence for this inexpensive, safe treatment and makes an eloquent argument for medical science to take another look at interferon to tackle today's most challenging health conditions, including COVID-19.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Simon + Schuster LLC
• Seitenzahl: 240
• Erscheinungstermin: 5. Januar 2021
• Englisch
• ISBN-13: 9781510765511
• Artikelnr.: 60135167

Autorenporträt

Dr. Joseph Cummins is a legendary figure in veterinary medicine, holder of sixteen US patents with sixty scientific publications, as well as making vital contributions in the field of HIV-AIDS research with leading scientists. Dr. Cummins did his undergraduate work at Ohio State University, served as a captain in the US Army, and received his doctorate in microbiology from the University of Missouri. In 1999, Dr. Cummins was named a Distinguished Alumnus from Ohio State University. In addition to his clinical work with animals, Dr. Cummins has taught at the University of Missouri, the University of Illinois, and Texas A & M University. Dr. Cummins is best known for his ground-breaking discoveries and research into the use of low-dose interferon, a simple, inexpensive therapy which he believes can successfully treat many human and animal conditions. Kent Heckenlively, JD, is a former attorney, a founding editor of Age of Autism, and a science teacher. During college Heckenlively worked for US Senator Pete Wilson, and in law school he was a writer and an editor of the school's law review and spent his summers working for the US Attorney's Office in San Francisco. Kent and his wife Linda live in Northern California with their two children, Jacqueline and Ben.